312 related articles for article (PubMed ID: 15469862)
1. Structural analysis and fatty acid-binding properties of two Croatian variants of human serum albumin.
Kragh-Hansen U; Campagnoli M; Dodig S; Nielsen H; Benko B; Raos M; Cesati R; Sala A; Galliano M; Minchiotti L
Clin Chim Acta; 2004 Nov; 349(1-2):105-12. PubMed ID: 15469862
[TBL] [Abstract][Full Text] [Related]
2. In vivo and in vitro binding of fatty acids to genetic variants of human serum albumin.
Kragh-Hansen U; Nielsen H; Pedersen AO
Int J Clin Pharmacol Res; 1995; 15(2):33-43. PubMed ID: 8593972
[TBL] [Abstract][Full Text] [Related]
3. Genetic variants of human serum albumin: molecular defects and biological stability.
Galliano M; Rossi A; Porta F; Minchiotti L
Int J Clin Pharmacol Res; 1995; 15(2):45-55. PubMed ID: 8593973
[TBL] [Abstract][Full Text] [Related]
4. [Human serum albumin: isoforms and analbuminemia].
Kragh-Hansen U
Ugeskr Laeger; 2008 May; 170(19):1638-43. PubMed ID: 18489873
[TBL] [Abstract][Full Text] [Related]
5. Chain length-dependent binding of fatty acid anions to human serum albumin studied by site-directed mutagenesis.
Kragh-Hansen U; Watanabe H; Nakajou K; Iwao Y; Otagiri M
J Mol Biol; 2006 Oct; 363(3):702-12. PubMed ID: 16979183
[TBL] [Abstract][Full Text] [Related]
6. Genetic variants showing apparent hot-spots in the human serum albumin gene.
Galliano M; Kragh-Hansen U; Tárnoky AL; Chapman JC; Campagnoli M; Minchiotti L
Clin Chim Acta; 1999 Nov; 289(1-2):45-55. PubMed ID: 10556652
[TBL] [Abstract][Full Text] [Related]
7. Binding of 3-carbethoxipsoralen to human serum albumin and human serum: influence of free fatty acids.
Font G; Mañes J; Martre H; Prognon P; Mahuzier G
Rev Esp Fisiol; 1987 Sep; 43(3):317-21. PubMed ID: 3423390
[TBL] [Abstract][Full Text] [Related]
8. Location of high and low affinity fatty acid binding sites on human serum albumin revealed by NMR drug-competition analysis.
Simard JR; Zunszain PA; Hamilton JA; Curry S
J Mol Biol; 2006 Aug; 361(2):336-51. PubMed ID: 16844140
[TBL] [Abstract][Full Text] [Related]
9. Structural characterization, stability and fatty acid-binding properties of two French genetic variants of human serum albumin.
Minchiotti L; Kragh-Hansen U; Nielsen H; Hardy E; Mercier AY; Galliano M
Biochim Biophys Acta; 1999 Apr; 1431(1):223-31. PubMed ID: 10209294
[TBL] [Abstract][Full Text] [Related]
10. Increase of plasma nonesterified fatty acid concentration and decrease of albumin binding affinity after intravenous injection of glycocholate-lecithin mixed micelles.
Guentert TW; Frey BM; Luedin E; Heinzl S; Brodersen R
J Lab Clin Med; 1990 Jul; 116(1):66-75. PubMed ID: 2376700
[TBL] [Abstract][Full Text] [Related]
11. Effect of genetic variation on the fatty acid-binding properties of human serum albumin and proalbumin.
Nielsen H; Kragh-Hansen U; Minchiotti L; Galliano M; Brennan SO; Tárnoky AL; Franco MH; Salzano FM; Sugita O
Biochim Biophys Acta; 1997 Oct; 1342(2):191-204. PubMed ID: 9392528
[TBL] [Abstract][Full Text] [Related]
12. Structural characterization of three genetic variants of human serum albumin modified in subdomains IIB and IIIA.
Galliano M; Watkins S; Madison J; Putnam FW; Kragh-Hansen U; Cesati R; Minchiotti L
Eur J Biochem; 1998 Jan; 251(1-2):329-34. PubMed ID: 9492301
[TBL] [Abstract][Full Text] [Related]
13. Molecular dynamics study of conformational changes in human serum albumin by binding of fatty acids.
Fujiwara S; Amisaki T
Proteins; 2006 Aug; 64(3):730-9. PubMed ID: 16783783
[TBL] [Abstract][Full Text] [Related]
14. Structural analysis, fatty acid and thyroxine binding properties of Vancouver and Naskapi variants of human serum albumin.
Campagnoli M; Kragh-Hansen U; Overgaard Pedersen A; Amoresano A; Lyon AW; Cesati R; Sala A; Romano A; Galliano M; Minchiotti L
Clin Biochem; 2003 Nov; 36(8):597-605. PubMed ID: 14636873
[TBL] [Abstract][Full Text] [Related]
15. [The characteristics of lipid ligand binding by serum albumin in athletes].
Tolkacheva NV; Levachev MM; Kulakova SN; Medvedev FA; Sorokina AG
Aviakosm Ekolog Med; 1992; 26(1):54-6. PubMed ID: 1299449
[TBL] [Abstract][Full Text] [Related]
16. Purification and structural study of two albumin variants in an Irish population.
Sakamoto Y; Davis E; Madison J; Watkins S; McLaughlin H; Leahy DT; Putnam FW
Clin Chim Acta; 1991 Dec; 204(1-3):179-87. PubMed ID: 1819460
[TBL] [Abstract][Full Text] [Related]
17. Expression of a human serum albumin variant with high affinity for thyroxine.
Petersen CE; Ha CE; Mandel M; Bhagavan NV
Biochem Biophys Res Commun; 1995 Sep; 214(3):1121-9. PubMed ID: 7575519
[TBL] [Abstract][Full Text] [Related]
18. Comparative studies of unfolding and binding of ligands to human serum albumin in the presence of fatty acid: spectroscopic approach.
Varshney A; Ahmad B; Khan RH
Int J Biol Macromol; 2008 Jun; 42(5):483-90. PubMed ID: 18452986
[TBL] [Abstract][Full Text] [Related]
19. Subdomain IIIA of dog albumin contains a binding site similar to site II of human albumin.
Kaneko K; Fukuda H; Chuang VT; Yamasaki K; Kawahara K; Nakayama H; Suenaga A; Maruyama T; Otagiri M
Drug Metab Dispos; 2008 Jan; 36(1):81-6. PubMed ID: 17925384
[TBL] [Abstract][Full Text] [Related]
20. Genetic engineering of the heme pocket in human serum albumin: modulation of O2 binding of iron protoporphyrin IX by variation of distal amino acids.
Komatsu T; Nakagawa A; Zunszain PA; Curry S; Tsuchida E
J Am Chem Soc; 2007 Sep; 129(36):11286-95. PubMed ID: 17705494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
